Helicobacter pylori Infection and Hepatobiliary Pathology by S. V. German, I. P. Bobrovnitsky

Subjects: Get full text

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg by V. P. Kovyazina, K. L. Raikhelson, M. K. Prashnova, E. V. Pazenko, L. K. Palgova, E. A. Kondrashina

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Geron... by V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The influence of gender and waist circumference in the association of body fat with cardiometabolic diseases by Milad Bagheri, Mehran Nouri, Ali Kohanmoo, Reza Homayounfar, Masoumeh Akhlaghi

Subjects: Get full text

ЖОРСТКІСТЬ ПАРЕНХІМИ ПЕЧІНКИ ЩУРІВ ПРИ МОДЕЛЮВАННІ СТЕАТОЗУ АЛІМЕНТАРНОГО ГЕНЕЗУ ТА ЙОГО КОРЕКЦІЇ... by В.І. Діденко, Ю.А. Гайдар, І.А. Кленіна, О.О. Галінський, І.С. Коненко, А.І. Руденко, О.І. Грабовська

Subjects: “…nonalcoholic fatty liver disease, morphological investigations, liver stiffness, shift wave elastography, steatosis, coenzyme q10, methadoxine…”
Get full text

Association Between Sociodemographic Variables, Healthy Habits, and Stress with Risk Scales for Liver Disease Associated with Metabolic Dysfunction by Ángel Arturo López-González, Emilio Martínez-Almoyna Rifá, Hernán Paublini Oliveira, Cristina Martorell Sánchez, Pedro Juan Tárraga López, José Ignacio Ramírez-Manent

Subjects: “…metabolic dysfunction-associated fatty liver disease (MAFLD)…”
Get full text

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) by V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

“…Original study included overall 180 patients with nonalcoholic fatty liver disease that were randomized to the basic and control groups in the ratio of 2:1. …”
Get full text

Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China by Guanghui Ma, Guohou Xu, Haixia Huang

Subjects: “…Non-alcoholic fatty liver disease…”
Get full text

Characteristics of different lipid droplet-mitochondrial contacts patterns during lipid droplet metabolism in T2DM-induced MASLD by Ye Xu, Yuan Zhang, Wen Sun, Qiang Tang, Wanyu Feng, Hongjian Xiao, Jingjie Wang, Xinmeng Yuan, Mengqi Xiang, Yaran Gao, Hanyu Zhang, Jiao Lu

Subjects: Get full text

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease by Myrsini Orfanidou, Stergios A. Polyzos

Subjects: Get full text

Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update by Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, Abdullah Hamadi, Zeyad M. Alharbi, Ruqaiah I. Bedaiwi, Jamsheed Javid, Tariq Alrasheed, Dalal Alatawi, Basmah M. Alrohaf, Mohammed K. Abunab, Turki Ahmed Muqri

Subjects: Get full text

Non-invasive methods for diagnosing portal hypertension and variceal bleeding due to liver cirrhosis secondary to NAFLD/MASLD: systematic review by Nebyu Yonas Shanka, Nebyu Yonas Shanka, Chavdar S. Pavlov, Nigatu Leul Mekonnen

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The rationale for the aggressive progression of MASLD in patients with type 2 diabetes by Valeria Michelle Fernández-Garibay, Norberto C. Chavez-Tapia

Subjects: “…NAFLD (non-alcoholic fatty liver disease)…”
Get full text

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation by K. L. Raikhelson, M. V. Maevskaya, M. S. Zharkova, V. R. Grechishnikova, S. V. Okovityi, T. A. Deeva, N. V. Marchenko, M. К. Prashnova, V. T. Ivashkin

Subjects: Get full text

Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice by Bülent Elitok, Ibrahim Kişlalioğlu, Yavuz Ulusoy, Bahadır Kilinç

“…Due the increasing number of alcoholic fatty liver disease cases in the world, the development of methods for treating this disease is an urgent task. …”
Get full text

Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik by Vanny Syafitri, Arnelis ., Efrida .

“…<p>Abstrak<br />Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease) merupakan kondisi klinis yang sering ditemukan dalam bidang hepatologi. …”
Get full text

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

“…In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver fibrosis-specific drug therapy and treatment for metabolic syndrome-related diseases. …”
Get full text

Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes by Amedeo Lonardo

“…Nonalcoholic fatty liver disease (NAFLD), its more rapidly progressive steatohepatitic variant [nonalcoholic steatohepatitis, (NASH)], and the recently defined metabolic dysfunction-associated fatty liver disease (MAFLD) may be collectively alluded to as “metabolic fatty liver syndromes” (MFLS). …”
Get full text

Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Res... by Fan Ping, Xuan Wang, Jing Yang, Mei-cen Zhou, Wei Li, Ling-ling Xu, Yu-xiu Li

“…The RNAFH study (effect of rosuvastatin on nonalcoholic fatty liver disease in metabolic syndrome patients without overt diabetes evaluated by 1H-MRS) is a prospective randomized, single-center, open-label trail designed to assess the effect of rosuvastatin on the intrahepatocellular lipid (IHCL) level of nonalcoholic fatty liver disease (NAFLD). …”
Get full text

Role of NKT Cells in the Pathogenesis of NAFLD by Kazuto Tajiri, Yukihiro Shimizu

“…Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease and shows various inflammatory changes in the liver. …”
Get full text